October 24, 2023

In a bold move that underscores their commitment to the future of fossil fuels, the two largest American oil companies, Chevron and ExxonMobil, have embarked on a race to secure petroleum reserves, defying predictions that global oil demand will peak by 2030. These multibillion-dollar transactions have set the stage for a seismic shift in the […]

Tech giants Microsoft and Alphabet (Google) have delivered strong quarterly results, potentially easing investor concerns about the megatechs’ ability to support the broader Wall Street market. Microsoft reported an impressive 27% increase in first-quarter profit, announced after Tuesday’s trading closed. In contrast, Alphabet saw double-digit revenue growth for the first time in over a year

For the fourth time since becoming Reserve Bank Governor, Michell Bullock has emphasised the central bank’s policy primacy in controlling prices by raising interest rates if inflation proves challenging to reduce. Less than a day before the release at 11:30 am on Wednesday of the Consumer Price Index for the September quarter and the CPI’s

Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses efficacy results for the company’s glioblastoma therapy. Peter Milios: I’m Peter Milios from the Finance News Network, and today we’re talking with Chimeric Therapeutics (ASX:CHM), market cap of around $14m. Chimeric Therapeutics is a clinical-stage therapy company focused on bringing the promise of cell

Stocks rose Tuesday as investors focused on a fresh slate of earnings reports. The Dow Jones Industrial Average gained 204 points, or 0.6 per cent. The S&P 500 added 0.7 per cent, and the Nasdaq Composite climbed 0.9 per cent. Coca-Cola reported earnings and revenue that topped estimates, sending the stock up 2.8 per cent.

On Tuesday, energy and mining stocks drove gains in the Australian sharemarket. Energy stocks benefited from the rise in oil prices, with West Texas Intermediate trading around $86 per barrel. The avoidance of a Gaza invasion by Tel Aviv temporarily eased Middle East tensions. As a result, Santos saw a 0.6% increase to $7.85, and

It looks like another year of forbearance for shareholders in Australia’s wannabe food giant, Bega Cheese (ASX:BGA). Shareholders were informed at Tuesday’s annual meeting that they shouldn’t expect significant earnings gains in the 2023-34 financial year. In fact, the company is anticipating a “relatively flat” result compared to the 2022-23 fiscal year when ‘normalised EBITDA’